Cantor Fitzgerald Starts Ovid Therapeutics Inc (OVID) at Overweight
Tweet Send to a Friend
Cantor Fitzgerald analyst Charles C. Duncan initiates coverage on Ovid Therapeutics ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
